Keratoconjunctivitis

• CLINICAL_TRIALS trial_result · 2025-05-21
  Clinical Trial Update: 3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis [NA]

  A completed 3-month study comparing Cationorm Pro with Vismed in adults with dry eye disease related to keratitis or keratoconjunctivitis.

• CLINICAL_TRIALS trial_result · 2025-05-21
  Clinical Trial Update: 3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis [NA]

  Clinical trial comparing Alocross with Vismed in adults with dry eye disease related to keratitis or keratoconjunctivitis is currently activ…

• CLINICAL_TRIALS trial_result · 2014-09-01
  Clinical Trial Update: Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis [Phase 3]

  Phase III trial evaluating 0.1% tacrolimus ophthalmic suspension for Vernal keratoconjunctivitis has completed.

• FDA approval · 2008-09-15
  FDA Approved: NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE — Supplemental Application (Sandoz Inc.)

  FDA approved a supplemental application for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (Sandoz) to support a generic version of thi…

• CLINICAL_TRIALS trial_result · 2008-04-04
  Clinical Trial Update: Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis [Phase 3]

  Phase III long-term, open-label extension study of 0.1% tacrolimus ophthalmic suspension in vernal keratoconjunctivitis completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.